Overview
| Name | Profluent-E1 · aliases: Profluent-E1, E1-600m |
|---|---|
| Full name | The paper refers to it as E1 and gives no expanded form |
| Ambiguous names (not auto-linked) | E1 |
| Family | Three parameter sizes from one paper sharing training set and licence; the sibling generative model is excluded
|
| Organization | Profluent |
| Organization type | AI-native biotech |
| Country | United States |
| Model class | Protein language model (retrieval-augmented encoder) |
| Domain | Proteins |
| First release | † unverified · paper revision Basis: Preprint v1, with weights posted at the same time Note: The DOI request failed, so the date was not reverified this round source |
| Other milestones | |
| Latest update | · maintenance only Basis: Repository changelog entry The repository changelog records one bug fix in the MSA sampling code and nothing else; no new weights. source The most recent sourced event, not a claim that nothing changed since. |
| Status | Maintained only · Only maintenance commits; no new version or weights |
| Openness | Code: Open · Apache-2.0 Weights: Open Code under Apache-2.0; weights under a permissive licence with attribution, which the developer states is free for research and commercial use |
| Benchmarks reported | 3 counted (self 1, retrospective 2) |
| Wet-lab validation | None recorded |
| Unverified fields | † first_release, release_milestones.paper_v1, release_milestones.code_release, release_milestones.weights_release, open_status.weights_license, training_data.b_private_licensed, benchmarks_reported |
| As of | 2026-11-16 |
What it does
An encoder that takes either a single sequence or retrieved homologues as context, used for mutation-effect scoring and representation. Its small size and retrieval mode set it apart from the sibling generative model ProGen3; PoET-2 works in the same in-context direction.
Benchmarks reported
Every row is one pairing from the survey's relation file; a score belongs to the benchmark page's ranking, where it is shown with metric, eval set, source type and date. 3 of 3 pairings are counted.
| Benchmark | Relation | Eval set / protocol | Source type | Note and evidence |
|---|---|---|---|---|
| 02 ProteinGym | Developer report, official protocol | — | Self-reported | Only a curve in the project README; no row on the official summary table †partly verified · evidence |
| 01 CASP | Retrospective dataset use | — | Third-party | CASP15 contact maps, numbers not retrieved †partly verified · evidence |
| 15 CAMEO | Retrospective dataset use | — | Third-party | CAMEO targets used post hoc; curve only. †partly verified · evidence |
Other evaluations (outside the 44)
- Comparison with similar-size protein language models (Comparison against baselines only) Self-reported: The repository plots size against metric alongside two open encoders and two in-context models
Developers report: the single-sequence mode beats two common open encoders at similar size and the retrieval mode surpasses two in-context models; the public material gives curves, not values.
Independent evidence: No independent evidence found. No entry for the model was found in the official leaderboard file as of 2026-11-16, and no third-party evaluation was found
Training data
Group in Figure 7: Public data only.
| Class | Value | Detail |
|---|---|---|
| a. Public databases | Yes | A genomic and metagenomic sequence set curated by the developer, with training reported at about 4 trillion tokens source |
| b. Private or licensed data | Not disclosed | The paper does not say whether the set contains licensed data source |
| c. Own wet-lab data used for training | No | |
| d. Wet lab used only for validation | No |
Wet-lab validation
None. The developers report no wet-lab validation.
Background
- Organization: The developer is an AI-native protein and gene-editing company founded in 2022 in California, reported at about 20 people in 2024 with no current public headcount.
- Funding: A $35M round in March 2024 and $106M on 19 November 2025, about $150M in total; the valuation is not officially disclosed, with media reporting it near $1B.
- Products and partnerships: The line-up includes a generative protein language model, this encoder and an open gene-editing protein; on 28 April 2026 a multi-programme recombinase collaboration with a large US pharmaceutical company was announced, with milestones up to $2.25B and an undisclosed upfront.
- Related models: ProGen3, PoET-2, ESM C
Reading notes
- Paper and repository give curves only, so claims of beating another model read as directional, not as checkable numbers.
- Retrieval-augmented and single-sequence models are not directly comparable on the same board; the mode must be matched first.
- The contact-map work reuses released targets from a continuous evaluation and one CASP round after the fact; it is not participation.
- The training set is a privately curated collection, so its composition cannot be reproduced externally.
Caveats
- The first-release date comes from the preprint; the DOI request failed this round, so it is marked unverified.
- The public material carries no per-model values, so no comparison can be rechecked.
- The official leaderboard file holds no entry for the model.
- Whether the training set contains licensed data is not disclosed.
- The latest event is a code bug fix, not a new version.
Sources
- Preprint 2025 (preprint)
- Preprint full text (preprint)
- Code repository (repository)
- Weights repository (600M) (repository)
Corrections
None recorded.
Part of the AI for Bio benchmarks survey · all 112 models · open in the explorer. Record as of 2026-11-16.